title: Non-myopathic cardiac events in two patients treated with trastuzumab.
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Olin
authors.forename: Shashank S
authors.initials: SS
authors.lastname: Desai
authors.forename: Kevin
authors.initials: K
authors.lastname: Fox
authors.forename: Rebecca
authors.initials: R
authors.lastname: Davidson
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000139:chemically induced; D001919:Bradycardia / Q000139:chemically induced; D001943:Breast Neoplasms / Q000628:therapy*; D002637:Chest Pain / Q000139:chemically induced*; D004562:Electrocardiography; D005260:Female; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D018365:Neoplasm, Residual / Q000628:therapy; D013575:Syncope / Q000139:chemically induced; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab